The President of Kazakhstan, Kassym-Jomart Tokayev, said that he had reached an agreement with Russian President Vladimir Putin on the construction of a plant in the country for the production of a Russian vaccine against coronavirus.  “I have reached an agreement with the President of Russia on the construction of a plant for the production of Russian vaccines. The government has already begun negotiations on attracting investments in this necessary project,” the press service of the President of Kazakhstan quotes Mr. Tokayev.

      At a meeting on measures to counter the spread of coronavirus infection, he said that two Kazakhstani vaccines were among the world's most promising biological products and undergoing clinical trials. According to him, now it is also important to continue work in all areas of biological safety: “Such measures are taken by all developed countries. Before the end of the current session of the parliament, it is necessary to submit a draft law on biosafety to the deputies for consideration. In Kazakhstan, 121,051 cases of coronavirus infection were detected. 1945 patients with COVID-19 died. More than 108 thousand patients have recovered. The Sputnik V vaccine was registered in Russia in August by the Gamaleya Center. Another registered vaccine was developed by the Novosibirsk center "Vector" - "EpiVacCorona". The Chumakov Center vaccine is undergoing clinical trials and will be ready by February.